US Patent Issued to ZHEJIANG UNIVERSITY on Jan. 27 for "Application of TREM2 hi macrophages in the preparation of drugs for the treatment of cardiac dysfunction" (Chinese Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,379, issued on Jan. 27, was assigned to ZHEJIANG UNIVERSITY (Hangzhou, China).

"Application of TREM2 hi macrophages in the preparation of drugs for the treatment of cardiac dysfunction" was invented by Xiangming Fang (Hangzhou, China), Kai Zhang (Hangzhou, China), Shiyu Chen (Hangzhou, China), Jiali Mao (Hangzhou, China) and Yang Wang (Hangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses an application of TREM2hi macrophages in preparation of drugs for treating cardiac dysfunction, and belongs to the technical field of medicine. The present invention discloses for the first time that there is a kind of macro...